Cost of corneal transplantation for the Quebec health care system.

OBJECTIVE Although corneal graft is a common, long-standing procedure, little is known about its economic impact. The purpose of this study was to estimate resource use and costs associated with corneal transplantation according to a public third-party perspective. DESIGN Retrospective study using claim data from the Régie de l'assurance maladie du Québec (RAMQ). PARTICIPANTS A total of 610 subjects were included in the study. Mean age was 54.8 (SD 20.4) years. METHODS The RAMQ provided medical and pharmaceutical data for a random sample of 75% of the patients who underwent a corneal graft procedure between June 1, 1999, and May 31, 2002. Resource usage data, defined as medical interventions, physician visits, and medication, were collected for a 3-year postoperative follow-up period. Hospital costs associated with corneal graft were obtained from the University of Montreal Hospital Centre costing system. RESULTS The average costs per patient for graft and anesthesia were $501 (SD $75) and $115 (SD $124), respectively. The mean cost per patient for physician visits was $276 (SD $146). The mean number of physician visits per patient during the follow-up was 14.9 (SD 9.1). The cost per patient for medication was $337 (SD $1075). The average total cost per patient was $1229 (SD $1125). Costs incurred by the hospital represented a total of $1942. CONCLUSIONS The overall cost of corneal graft, including a 3-year follow-up, was estimated at $3171 ($1229 RAMQ, $1942 hospital). The majority of these costs occurred at the time of the procedure.

[1]  黄亚明 eMedicine , 2009 .

[2]  E. Cohen,et al.  Indications for Penetrating Keratoplasty and Associated Procedures, 2001–2005 , 2008, Eye & contact lens.

[3]  A. Behrens,et al.  Incidence of acute endophthalmitis following penetrating keratoplasty: a systematic review. , 2005, Archives of ophthalmology.

[4]  W. H. Lee,et al.  Opinions on Risk Factors and Management of Corneal Graft Rejection in the United Kingdom , 2005, Cornea.

[5]  D. Coster,et al.  Management of high-risk corneal grafts , 2003, Eye.

[6]  P. Doornenbal,et al.  Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. , 2003, Ophthalmology.

[7]  Robert W. Thompson,et al.  Long-term graft survival after penetrating keratoplasty. , 2003, Ophthalmology.

[8]  E. S. Arcieri,et al.  A Study of Glaucoma After Penetrating Keratoplasty , 2002, Cornea.

[9]  E. Cohen,et al.  Indications for Penetrating Keratoplasty and Associated Procedures, 1996–2000 , 2002, Cornea.

[10]  C. McGhee,et al.  Indications for Corneal Transplantation in New Zealand: 1991–1999 , 2002, Cornea.

[11]  D. Coster,et al.  Current Australian practice in the prevention and management of corneal allograft rejection , 2000, Clinical & experimental ophthalmology.

[12]  R. Ayyala,et al.  Penetrating keratoplasty and glaucoma. , 2000, Survey of ophthalmology.

[13]  J. Naor,et al.  Three decades of corneal transplantation: indications and patient characteristics. , 2000, Cornea.

[14]  Y. Akova,et al.  Microbial keratitis following penetrating keratoplasty. , 1999, Ophthalmic surgery and lasers.

[15]  E. Cohen,et al.  Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. , 1999, Archives of ophthalmology.

[16]  Y. Akova,et al.  Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis. , 1999, Ocular immunology and inflammation.

[17]  R. D. Stulting,et al.  Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. , 1998, The New England journal of medicine.

[18]  J. LeLorier,et al.  Management of new symptoms of dyspepsia in the elderly in Quebec. , 1997, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[19]  A. Slomovic,et al.  Indications for penetrating keratoplasty in Canada, 1986-1995. , 1997, Cornea.

[20]  R. D. Stulting,et al.  Current Practices in the Prevention and Treatment of Corneal Graft Rejection , 1992, Cornea.